SanaCurrents Probability Sentiment

//SanaCurrents Probability Sentiment

ADMA New Catalysts For 2019 – Two PDUFA decisions on immunodeficiency therapies

SUMMARY SanaCurrents assigns a pivotal sentiment the FDA will approve [...]

Cara Therapeutics (CARA) Q1 2019 Catalyst: Phase III efficacy trial, KALM-2

SUMMARY Sana Currents assigns a pivotal sentiment that Cara Therapeutics [...]

ADMA Biologics (NASDAQ:ADMA) December Catalyst: PDUFA for BIVIGAM

SanaCurrents assigns a pivotal sentiment the FDA will approve the [...]

Hemophilia Treatment Company Catalyst Biosciences’ Antibody Update May Catalyze Shares

Catalyst Biosciences, Inc. (NASDAQ:CBIO) , a company that is developing improved [...]

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) – 3Q 2019 catalyst, CBD treatment for Fragile X

3Q ‘19 catalyst, CBD treatment for Fragile X SanaCurrents is [...]

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) – December Catalyst, Lymphoma Phase IIb Trial

December catalyst, lymphoma phase IIb trial SanaCurrents assigns a pivotal [...]

Galmed (GLMD) – November Catalyst: Aramchol

November Catalyst: Aramchol SanaCurrents forecasts an advantageous probability Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) [...]

Top
SSL